313 related articles for article (PubMed ID: 33895869)
1. ApoE4 inhibition of VMAT2 in the locus coeruleus exacerbates Tau pathology in Alzheimer's disease.
Kang SS; Ahn EH; Liu X; Bryson M; Miller GW; Weinshenker D; Ye K
Acta Neuropathol; 2021 Jul; 142(1):139-158. PubMed ID: 33895869
[TBL] [Abstract][Full Text] [Related]
2. Locus Coeruleus Ablation Exacerbates Cognitive Deficits, Neuropathology, and Lethality in P301S Tau Transgenic Mice.
Chalermpalanupap T; Schroeder JP; Rorabaugh JM; Liles LC; Lah JJ; Levey AI; Weinshenker D
J Neurosci; 2018 Jan; 38(1):74-92. PubMed ID: 29133432
[TBL] [Abstract][Full Text] [Related]
3. Norepinephrine metabolite DOPEGAL activates AEP and pathological Tau aggregation in locus coeruleus.
Kang SS; Liu X; Ahn EH; Xiang J; Manfredsson FP; Yang X; Luo HR; Liles LC; Weinshenker D; Ye K
J Clin Invest; 2020 Jan; 130(1):422-437. PubMed ID: 31793911
[TBL] [Abstract][Full Text] [Related]
4. Tau modification by the norepinephrine metabolite DOPEGAL stimulates its pathology and propagation.
Kang SS; Meng L; Zhang X; Wu Z; Mancieri A; Xie B; Liu X; Weinshenker D; Peng J; Zhang Z; Ye K
Nat Struct Mol Biol; 2022 Apr; 29(4):292-305. PubMed ID: 35332321
[TBL] [Abstract][Full Text] [Related]
5. Roles of tau pathology in the locus coeruleus (LC) in age-associated pathophysiology and Alzheimer's disease pathogenesis: Potential strategies to protect the LC against aging.
Satoh A; Iijima KM
Brain Res; 2019 Jan; 1702():17-28. PubMed ID: 29274876
[TBL] [Abstract][Full Text] [Related]
6. Down but Not Out: The Consequences of Pretangle Tau in the Locus Coeruleus.
Chalermpalanupap T; Weinshenker D; Rorabaugh JM
Neural Plast; 2017; 2017():7829507. PubMed ID: 29038736
[TBL] [Abstract][Full Text] [Related]
7. Tau seeding activity begins in the transentorhinal/entorhinal regions and anticipates phospho-tau pathology in Alzheimer's disease and PART.
Kaufman SK; Del Tredici K; Thomas TL; Braak H; Diamond MI
Acta Neuropathol; 2018 Jul; 136(1):57-67. PubMed ID: 29752551
[TBL] [Abstract][Full Text] [Related]
8. Chemogenetic locus coeruleus activation restores reversal learning in a rat model of Alzheimer's disease.
Rorabaugh JM; Chalermpalanupap T; Botz-Zapp CA; Fu VM; Lembeck NA; Cohen RM; Weinshenker D
Brain; 2017 Nov; 140(11):3023-3038. PubMed ID: 29053824
[TBL] [Abstract][Full Text] [Related]
9. An experimental model of Braak's pretangle proposal for the origin of Alzheimer's disease: the role of locus coeruleus in early symptom development.
Ghosh A; Torraville SE; Mukherjee B; Walling SG; Martin GM; Harley CW; Yuan Q
Alzheimers Res Ther; 2019 Jul; 11(1):59. PubMed ID: 31266535
[TBL] [Abstract][Full Text] [Related]
10. Reduced vesicular storage of catecholamines causes progressive degeneration in the locus ceruleus.
Taylor TN; Alter SP; Wang M; Goldstein DS; Miller GW
Neuropharmacology; 2014 Jan; 76 Pt A(0 0):97-105. PubMed ID: 24025942
[TBL] [Abstract][Full Text] [Related]
11. Neuron-specific apolipoprotein e4 proteolysis is associated with increased tau phosphorylation in brains of transgenic mice.
Brecht WJ; Harris FM; Chang S; Tesseur I; Yu GQ; Xu Q; Dee Fish J; Wyss-Coray T; Buttini M; Mucke L; Mahley RW; Huang Y
J Neurosci; 2004 Mar; 24(10):2527-34. PubMed ID: 15014128
[TBL] [Abstract][Full Text] [Related]
12. Tau pathology spread in PS19 tau transgenic mice following locus coeruleus (LC) injections of synthetic tau fibrils is determined by the LC's afferent and efferent connections.
Iba M; McBride JD; Guo JL; Zhang B; Trojanowski JQ; Lee VM
Acta Neuropathol; 2015 Sep; 130(3):349-62. PubMed ID: 26150341
[TBL] [Abstract][Full Text] [Related]
13. Elevated norepinephrine metabolism is linked to cortical thickness in the context of Alzheimer's disease pathology.
van Hooren RWE; Verhey FRJ; Ramakers IHGB; Jansen WJ; Jacobs HIL
Neurobiol Aging; 2021 Jun; 102():17-22. PubMed ID: 33667876
[TBL] [Abstract][Full Text] [Related]
14. ApoE4 induces Aβ42, tau, and neuronal pathology in the hippocampus of young targeted replacement apoE4 mice.
Liraz O; Boehm-Cagan A; Michaelson DM
Mol Neurodegener; 2013 May; 8():16. PubMed ID: 23684315
[TBL] [Abstract][Full Text] [Related]
15. Intracerebral Expression of AAV-APOE4 Is Not Sufficient to Alter Tau Burden in Two Distinct Models of Tauopathy.
Koller EJ; Gonzalez De La Cruz E; Weinrich M; Williams T; Cruz PE; Ryu D; Golde TE; Sullivan PM; Lewis J; Borchelt DR; Chakrabarty P
Mol Neurobiol; 2020 Apr; 57(4):1986-2001. PubMed ID: 31903524
[TBL] [Abstract][Full Text] [Related]
16. Consequences of Hyperphosphorylated Tau in the Locus Coeruleus on Behavior and Cognition in a Rat Model of Alzheimer's Disease.
Kelberman MA; Anderson CR; Chlan E; Rorabaugh JM; McCann KE; Weinshenker D
J Alzheimers Dis; 2022; 86(3):1037-1059. PubMed ID: 35147547
[TBL] [Abstract][Full Text] [Related]
17. Sparse Asymmetry in Locus Coeruleus Pathology in Alzheimer's Disease.
Beckers E; Riphagen JM; Van Egroo M; Bennett DA; Jacobs HIL
J Alzheimers Dis; 2024; 99(1):105-111. PubMed ID: 38607758
[TBL] [Abstract][Full Text] [Related]
18. Cleavage of tau by asparagine endopeptidase mediates the neurofibrillary pathology in Alzheimer's disease.
Zhang Z; Song M; Liu X; Kang SS; Kwon IS; Duong DM; Seyfried NT; Hu WT; Liu Z; Wang JZ; Cheng L; Sun YE; Yu SP; Levey AI; Ye K
Nat Med; 2014 Nov; 20(11):1254-62. PubMed ID: 25326800
[TBL] [Abstract][Full Text] [Related]
19. Traumatic brain injury triggers APP and Tau cleavage by delta-secretase, mediating Alzheimer's disease pathology.
Wu Z; Wang ZH; Liu X; Zhang Z; Gu X; Yu SP; Keene CD; Cheng L; Ye K
Prog Neurobiol; 2020 Feb; 185():101730. PubMed ID: 31778772
[TBL] [Abstract][Full Text] [Related]
20. Delta-secretase cleavage of Tau mediates its pathology and propagation in Alzheimer's disease.
Kang SS; Ahn EH; Ye K
Exp Mol Med; 2020 Aug; 52(8):1275-1287. PubMed ID: 32859953
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
